Document is current
Any future updates will be listed below
-
Authors
Mendiola, Andrew S. http://orcid.org/0000-0002-2897-3299
Yan, Zhaoqi http://orcid.org/0000-0001-9326-2920
Dixit, Karuna http://orcid.org/0000-0003-3583-2512
Johnson, Jeffrey R.
Bouhaddou, Mehdi
Meyer-Franke, Anke
Shin, Min-Gyoung
Yong, Yu
Agrawal, Ayushi http://orcid.org/0000-0003-2940-8926
MacDonald, Eilidh http://orcid.org/0009-0009-3033-0653
Muthukumar, Gayathri
Pearce, Clairice
Arun, Nikhita
Cabriga, Belinda
Meza-Acevedo, Rosa
Alzamora, Maria del Pilar S. http://orcid.org/0000-0001-8861-387X
Zamvil, Scott S. http://orcid.org/0000-0003-2720-9915
Pico, Alexander R. http://orcid.org/0000-0001-5706-2163
Ryu, Jae Kyu http://orcid.org/0000-0002-3992-4011
Krogan, Nevan J. http://orcid.org/0000-0003-4902-337X
Akassoglou, Katerina http://orcid.org/0000-0002-2632-1465
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R35 NS097976, K99 NS126707)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (RF1 AG064926)
BrightFocus Foundation (82021019F)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (K99 AI163868)
- License Information
-
More Information
Article History
Received: 4 November 2021
Accepted: 24 April 2023
First Online: 8 June 2023
Competing interests
: K.A. is the scientific founder, advisor and shareholder of Therini Bio, Inc. Her interests are managed by Gladstone Institutes according to its conflict of interest policy. The Krogan Laboratory has received research support from Vir Biotechnology, F. Hoffmann-La Roche and Rezo Therapeutics. N.J.K. has financially compensated consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics, Interline Therapeutics, Rezo Therapeutics, GEn1E Lifesciences, Inc. and Twist Bioscience Corp. He is on the Board of Directors of Rezo Therapeutics and is a shareholder in Tenaya Therapeutics, Maze Therapeutics, Rezo Therapeutics and Interline Therapeutics.
